Pancreatic Carcinoma — Research

Pancreatic Carcinoma — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-12	73,406	`("Pancreatic Carcinoma"[tiab] OR "Pancreas Cancer"[tiab] OR "Pancreatic Cancer"[tiab] OR "Carcinoma of Pancreas"[tiab] OR "Carcinoma of the Pancreas"[tiab])`	2026-09-12	pubmed
Last 5 years	2021-01-01 → 2026-12-31	26,375	`("Pancreatic Carcinoma"[tiab] OR "Pancreas Cancer"[tiab] OR "Pancreatic Cancer"[tiab] OR "Carcinoma of Pancreas"[tiab] OR "Carcinoma of the Pancreas"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-12	pubmed
Last 12 months	2025-09-12 → 2026-09-12	5,432	`("Pancreatic Carcinoma"[tiab] OR "Pancreas Cancer"[tiab] OR "Pancreatic Cancer"[tiab] OR "Carcinoma of Pancreas"[tiab] OR "Carcinoma of the Pancreas"[tiab]) AND (2025/09/12:2026/09/12[dp])`	2026-09-12	pubmed

Data updated 18 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (31)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–25 of 31 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
· N Engl J Med · 2019 · PMID 31157963 · validated civic_curation pubmed
Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer.
· N Engl J Med · 2025 · PMID 39908431 · validated civic_curation pubmed
A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas.
· Eur J Cancer · 2014 · PMID 24915778 · validated civic_curation pubmed
Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma.